Concepedia

Bailong Xin

BX

2

Publications

367

Citations

2

H-Index

2008

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bailong Xin is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, pharmacotherapy, and thrombosis.

ORCID

Top concepts

Publications per year

2008–2009

2

Publications

2

Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies

Pancras C. Wong, Earl J. Crain, Bailong Xin et al. · Journal of Thrombosis and Haemostasis · 2008 · 299 citations · Full text

, , +8

Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits

Pancras C. Wong, Earl J. Crain, Carol A. Watson et al. · Journal of Thrombosis and Haemostasis · 2009 · 68 citations

, , +9

Rows per page

1–2 of 2